ÜBER DIESEN PODCAST 🔗

Aktualisierungshäufigkeit:
daily
Durchschnittliche Audiolänge:
50 minutes
Gastinterviews
Englisch
Vereinigte Staaten
944 Folgen
seit 4. Dezember 2020
episodic

AUDIENCE OF THIS PODCAST 🔗

~78.12% of listeners are from United States.
🇺🇸
US
78.12%
🇸🇬
SG
8.12%
🇨🇦
CA
4.68%
🇩🇪
DE
2.50%
🇬🇧
GB
1.56%
🇦🇺
AU
1.25%
🇳🇱
NL
0.93%
🇮🇪
IE
0.62%
🇭🇰
HK
0.62%
🇳🇿
NZ
0.31%
🇪🇸
ES
0.31%
🇵🇭
PH
0.31%
🇯🇴
JO
0.31%
🇮🇹
IT
0.31%
Others
0.05%
* Data source: directly measured on Listen Notes. in Echtzeit

NEUESTE FOLGEN 🔗

Send us Fan Mail Nuclear power has a scale problem: conventional plants are enormous, expensive projects that can take years to build. Hadron Energy wants to take a different approach with a factory-manufactured, 10-megawatt light-water microreactor. But can a smaller reactor actually mean lower co…

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Progress, Potential, and Possibilities Podcast / Show durchsuchen.

FRÜHERE EPISODEN

Send us Fan Mail The world doesn't have a shortage of promising medical discoveries. The real challenge is turning those discoveries into safe, effective, accessible treatments. What separates a breakthrough idea from a successful therapy? How could AI change the economics of drug development?…
Send us Fan Mail What if we stopped thinking about antibodies as simply drugs that bind to one target - and started thinking about them as engineered molecular machines? Today we're talking about a bispecific antibody that targets both EGFR and LGR5, and asking whether that kind of antibody en…
Send us Fan Mail What happens when you're 19 years old, physically fit, a collegiate wrestler, and you suddenly find yourself hospitalized for three days with influenza? Today's guest, Zachery Lang, experienced exactly that - and his story offers an important perspective on a disease many…
Send us Fan Mail Homelessness, addiction, mental health, aging and incarceration are often treated as separate problems. But for the people experiencing them, they're frequently connected. What would it take to build a system that sees the whole person - and could emerging technology help us g…
Send us Fan Mail What if the next breakthrough in diabetes treatment isn't necessarily a new drug molecule, but a better way to deliver the drugs we already have? One biotechnology company is developing a platform designed to target the liver with insulin - and exploring whether the same princ…
Send us Fan Mail Cancer medicine is advancing rapidly. But are patients getting the tests and treatments they need to benefit from those advances?Chronic lymphocytic leukemia, or CLL, is one of the most common forms of adult leukemia. And while advances in targeted therapies have transformed the tr…
Send us Fan Mail The brain is one of the most complex systems in biology, and understanding it requires more than a picture of its anatomy. We need to understand its connections, activity, and response to injury. Today we're going to ask a fascinating question: Can advanced neuroimaging and ar…
Send us Fan Mail We usually assume that before we can use electricity somewhere, we need to build the infrastructure to deliver it. But what if we could bring the energy infrastructure to the location instead? That's the idea behind Beam Global's approach to solar-powered EV charging, ene…
Send us Fan Mail A drug can look promising in the laboratory and still fail when it reaches human testing. One of the biggest challenges in drug development is predicting what a compound will actually do inside the human body - including whether it will cause dangerous side effects. Could AI help u…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Ira Pastor, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.